Clinical Challenge: Skin Reaction in Cancer Patient
A 74-year-old man presents to the oncology infusion center 1 week after receiving an intravenous dose of enfortumab vedotin-ejfv. His right arm has a large erythema and blister. Can you make the correct diagnosis?